CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Choice (TPC) in advanced metastatic or locally recurrent breast cancer (aMBC) patients with no approved alternative therapies avail...
Phase 3
Orlando, Florida, United States and 35 other locations
A phase 1b study to assess the combination of ARV-471 and everolimus in participants with advanced or metastatic ER+/HER2- breast cancer...
Phase 1
Lake Mary, Florida, United States and 8 other locations
breast biopsy occurs if biopsy is needed....
Port Orange, Florida, United States and 3 other locations
A Global, Phase 2 Study of ARX788 in HER2-positive Metastatic Breast Cancer Patients who were previously treated with T-DXd...
Phase 2
Orlando, Florida, United States and 62 other locations
to anti-HER2-based therapy plus endocrine therapy alone in improving the outcomes of subjects with hormone receptor-positive, HER2+ metastatic breast...
Phase 3
Orlando, Florida, United States and 117 other locations
postmenopausal women with locally advanced or metastatic ER+/HER2- breast cancer with an acquired ESR1 mutation and who have diseas...
Phase 2
Winter Haven, Florida, United States and 50 other locations
positive (HR+) and human epidermal growth factor 2 negative (HER2-) breast cancer (BC) and other advanced solid tumors. Th...
Phase 1
Lake Mary, Florida, United States and 64 other locations
ARV-471 (PF-07850327) given together with palbociclib in advanced breast cancer. In particular, the study will compare the combinat ...
Phase 3
Orange City, Florida, United States and 40 other locations
A study to learn about a new medicine called ARV-471 (PF-07850327) in people who have advanced metastatic breast cancer....
Phase 3
Orlando, Florida, United States and 446 other locations
oral immuno-oncology product candidate targeting immune-suppressive tumor-associated myeloid cells through selective inhibition of phosphoin...
Phase 2
Orlando, Florida, United States and 23 other locations
Clinical trials
Research sites
Resources
Legal